North America Biobanking Market is Anticipated to Reach USD 2.27 billion by 2033, Growing at a CAGR of 8.6% from 2025 to 2033 | QIAGEN N.V., PHC Corporation, Merck KGaA.

The North America biobanking market reached US$ 1.09 billion in 2024 and is expected to reach US$ 2.27 billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.

North America Biobanking Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/north-america-biobanking-market?sz

The North America Biobanking market focuses on the collection, storage, and management of biological samples for research and clinical purposes. Driven by advancements in personalized medicine, increasing research activities, and a growing focus on genomics and disease prevention, the market is expanding as academic institutions, hospitals, and pharmaceutical companies invest in biobank infrastructure for improving diagnostics and treatment development.

List of the Key Players in the North America Biobanking Market:

Thermo Fisher Scientific Inc., QIAGEN N.V., PHC Corporation, Merck KGaA, Avantor, Inc., Cryoport Systems, LLC., Tecan Group Ltd., Azenta US Inc., Greiner Bio-One North America Inc., Hamilton Company and among others.

Market Dynamics:

Rapid Advancements in Biotechnology & Genomic Research

The rapid advancements in biotechnology and genomic research are significantly driving the growth of the biobanking market in North America and are expected to continue fueling its expansion in the coming years. Biotechnology and genomics have paved the way for the development of personalized treatments and targeted therapies, which is enhancing the demand for biobanks.

Biobanks are essential in providing the genetic samples needed to identify biomarkers and genetic variations in diseases such as cancer, cardiovascular conditions, and neurological disorders. These insights are crucial for developing drugs tailored to specific genetic profiles, thereby increasing the need for biological samples. For example, advancements by companies like Illumina in genomic sequencing, such as next-generation sequencing (NGS), generate massive amounts of data, which require robust sample storage and data management. This, in turn, supports applications in genomics, transcriptomics, and epigenomics, further driving the demand for biobank services.

Growth Forecast Projected:

The Global North America Biobanking Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global North America Biobanking Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/north-america-biobanking-market

Segment Covered in the North America Biobanking Market:

By Specimen Type: Blood, Tissues, Cell Lines, Nucleic Acids, Others.

By Product & Services: Equipments, Consumables, Services, Software.

By Storage Type: Manual Storage, Automated Storage.

By Application: Therapeutic Research, Life Science Research, Regenerative Medicine, Clinical Diagnostics, Personalized Medicine, Others.

By End-User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Others.

Regional Analysis for North America Biobanking Market:

The regional analysis of the North America Biobanking Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/north-america-biobanking-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the North America Biobanking market?

➠ Who are the leading manufacturers in the global North America Biobanking industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global North America Biobanking industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the North America Biobanking market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/north-america-biobanking-market

Biobanking Services Market: https://www.datamintelligence.com/research-report/biobanking-services-market/sz

Stem Cell Banking Market: https://www.datamintelligence.com/download-sample/stem-cell-banking-market?sz

Allogeneic Stem Cells Market: https://www.datamintelligence.com/download-sample/allogeneic-stem-cells-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.